Pathologic response rates for breast cancer stages as a predictor of outcomes in patients receiving neoadjuvant chemotherapy followed by breast-conserving surgery-Reference-Cited by-同舟云学术

Pathologic response rates for breast cancer stages as a predictor of outcomes in patients receiving neoadjuvant chemotherapy followed by breast-conserving surgery

Published:2021-03 Issue: Volume:36 Page:91-98
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Zhang Jiaqiang,Lu Chang-Yun,Chen Ho-Min,Wu Szu-Yuan^ORCID

Funder

Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference41 articles.

1. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials;Early Breast Cancer Trialists' Collaborative;Lancet Oncol.,2018

2. Neoadjuvant treatment of breast cancer;Thompson;Ann. Oncol.,2012

3. How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study;Mamtani;Ann. Surg Oncol.,2016

4. Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy;Tanioka;Br. J. Canc.,2010

5. Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer;Kim;Ann. Oncol.,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term overall survival of patients who undergo breast-conserving therapy or mastectomy for early operable HER2-Positive breast cancer after preoperative systemic therapy: an observational cohort study;The Lancet Regional Health - Americas;2024-04

2. Maintenance chemotherapy for esophageal squamous cell carcinoma after standard concurrent chemoradiotherapy: a national propensity score matching cohort study;American Journal of Cancer Research;2024

3. Comparative Effectiveness of Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Patients With Inoperable Esophageal Squamous Cell Carcinoma Undergoing Curative-Intent Concurrent Chemoradiotherapy;Journal of Thoracic Oncology;2023-12

4. Preoperative downstaging of pancreatic cancer is associated with improved survival after multi-agent chemotherapy, but not after radiation;Surgical Oncology;2023-06

5. Impact of margin width on local recurrence after breast conservative surgery following neoadjuvant chemotherapy;Journal of Pharmaceutical Negative Results;2022-10-10